$5.64 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 290 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 5.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AEGERIONnote2 | $20,695,000,000 | +0.1% | 26,000,000 | 0.0% | 0.37% | +22.3% | ||
TPGHU | TPG PACEunit9 | $10,330,000,000 | +0.3% | 1,000,000 | 0.0% | 0.18% | +22.0% | |
GOODRICHdebt1 | $3,097,000,000 | +13.2% | 4,874,999 | 0.0% | 0.06% | +37.5% | ||
OREXIGENnote2 | $2,780,000,000 | -7.3% | 7,500,000 | 0.0% | 0.05% | +11.4% | ||
OREXIGENnote2 | $2,550,000,000 | -15.0% | 7,500,000 | 0.0% | 0.04% | +2.3% | ||
ALLSCRIPnote1 | $1,073,000,000 | +1.0% | 1,000,000 | 0.0% | 0.02% | +26.7% | ||
BIOMARINnote0 | $1,087,000,000 | -3.0% | 1,000,000 | 0.0% | 0.02% | +18.8% | ||
ILLUMINAnote6 | $1,090,000,000 | +2.8% | 1,000,000 | 0.0% | 0.02% | +26.7% | ||
INFINERAdbcv1 | $991,000,000 | -3.5% | 1,000,000 | 0.0% | 0.02% | +20.0% | ||
TWITTERnote0 | $958,000,000 | +0.8% | 1,000,000 | 0.0% | 0.02% | +21.4% | ||
NUANCE Cdbcv1 | $959,000,000 | +1.9% | 1,000,000 | 0.0% | 0.02% | +21.4% | ||
ACORDA Tnote1 | $852,000,000 | -6.2% | 1,000,000 | 0.0% | 0.02% | +15.4% | ||
THC | TENET HE | $758,000,000 | -7.8% | 50,000 | 0.0% | 0.01% | +8.3% | |
GCVRZ | SANOFIright | $470,000,000 | +5.4% | 1,238,077 | 0.0% | 0.01% | +33.3% | |
PLX | PROTALIX | $215,000,000 | +14.4% | 324,479 | 0.0% | 0.00% | +33.3% | |
CYHHZ | COMMUNITright | $36,000,000 | -39.0% | 5,055,677 | 0.0% | 0.00% | 0.0% | |
OREXQ | OREXIGEN | $0 | – | 33,333 | 0.0% | 0.00% | – | |
WIN | WINDSTREput | $5,000,000 | -77.3% | 254,000 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
META PLATF | 36 | Q3 2023 | 2.3% |
SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
ACTIVISION | 29 | Q3 2023 | 71.3% |
AMAZON COM | 29 | Q3 2023 | 0.8% |
GAMING & L | 29 | Q3 2023 | 0.8% |
SPDR S&P | 29 | Q1 2023 | 0.1% |
DISNEY W | 28 | Q3 2021 | 2.0% |
POST HLD | 27 | Q2 2020 | 1.8% |
GENERAL | 27 | Q3 2022 | 1.4% |
CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-06-06 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.